The Active Surveillor: When the Best Treatment is No Treatment episode artwork

EPISODE · Feb 8, 2024 · 1H 11M

The Active Surveillor: When the Best Treatment is No Treatment

from Stay in the Game

Before he created The Active Surveillor.com, Howard Wolinsky was a medical writer for the Chicago Sun-Times for nearly thirty years and a regular contributor to MedPage Today and Medscape. When he was diagnosed with Gleason 6 (now also called GG1) prostate he said no thanks as he was being rushed to take on a radical treatment option. Thirteen years down the road from his cancer diagnosis he is one of the country's most passionate advocates for active surveillance as a first (and possibly forever) step to indolent/favorable diagnoses of prostate cancer. Program Notes Links for Howard Wolinsky Howard Wolinsky on LinkedIn: linkedin.com/in/howardwolinsky Subscribe to The Active Surveillor: https://howardwolinsky.substack.com/ Howard's story in STAT News: https://www.statnews.com/2022/01/11/active-surveillance-for-prostate-cancer-the-gift-that-keeps-on-giving/ How Wolinsky became an advocate: https://www.medpagetoday.com/hematologyoncology/prostatecancer/63251 Links for Active Surveillance Feature on Active Surveillance in the New York Times: https://www.nytimes.com/2020/03/02/well/live/before-prostate-surgery-consider-active-surveillance.html Most men with low-risk prostate cancer now opt for acttive surveillance. or monitoring: https://www.medscape.com/viewarticle/974009 More than 60% of U.S. men with low-risk prostate cancer are now opting for active surveillance or monitoring: https://www.medscape.com/viewarticle/974009 Additional Links for Prostate Cancer Understanding why Secretary Austin wanted to keep his cancer a secret, but how he can help other patients by opening up: https://www.medpagetoday.com/special-reports/apatientsjourney/108309 The risks of transrectal biopsies: https://www.medpagetoday.com/special-reports/apatientsjourney/92201 The debate between transrectal and transperineal prostate biopsy methods: https://www.medscape.com/viewarticle/991496 Is low-risk disease really prostate cancer? https://www.medpagetoday.com/special-reports/apatientsjourney/90601

Episode metadata supplied by the publisher feed · Published Feb 8, 2024

Embed this episode

NOW PLAYING

The Active Surveillor: When the Best Treatment is No Treatment

0:00 1:11:40

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Stay in the Game?

This episode is 1 hour and 11 minutes long.

When was this Stay in the Game episode published?

This episode was published on February 8, 2024.

Can I download this Stay in the Game episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!